Equities

Zhaoke Ophthalmology Ltd

Zhaoke Ophthalmology Ltd

Actions
  • Price (HKD)1.37
  • Today's Change0.02 / 1.48%
  • Shares traded704.00k
  • 1 Year change-59.59%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,4621,7252,137
Total Receivables, Net234815
Total Inventory6.14----
Prepaid expenses392732
Other current assets, total26617226
Total current assets1,7951,9732,209
Property, plant & equipment, net224234184
Goodwill, net------
Intangibles, net392335162
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets2,4202,5712,605
LIABILITIES
Accounts payable1.17----
Accrued expenses1016330
Notes payable/short-term debt2079510
Current portion long-term debt/capital leases9.599.735.88
Other current liabilities, total192743
Total current liabilities33619589
Total long term debt222821
Total debt23813237
Deferred income tax------
Minority interest------
Other liabilities, total140.010.05
Total liabilities372222110
SHAREHOLDERS EQUITY
Common stock000
Additional paid-in capital5,4445,4285,414
Retained earnings (accumulated deficit)(3682)(3304)(2933)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total28622514
Total equity2,0482,3482,495
Total liabilities & shareholders' equity2,4202,5712,605
Total common shares outstanding546544542
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.